0R15 9025.0 0.0% 0R1E 9410.0 0.0% 0M69 None None% 0R2V 247.99 9682.643% 0QYR 1567.5 0.0% 0QYP 439.3701 -2.9016% 0RUK None None% 0RYA 1597.0 1.2682% 0RIH 195.55 0.0% 0RIH 191.4 -2.1222% 0R1O 225.5 9683.0803% 0R1O None None% 0QFP 10475.8496 107.8542% 0M2Z 252.573 0.2373% 0VSO 33.0 -7.3164% 0R1I None None% 0QZI 622.0 0.0% 0QZ0 220.0 0.0% 0NZF None None% 0YXG 222.05 -4.1318%

Animalcare Group Plc

Healthcare GB ANCR

240.0GBP
-1.0(0.41%)

Last update at 2024-12-19T16:35:00Z

Day Range

238.85240.50
LowHigh

52 Week Range

141.49229.32
LowHigh

Fundamentals

  • Previous Close 241.00
  • Market Cap105.19M
  • Volume17771
  • P/E Ratio85.00
  • Dividend Yield2.59%
  • EBITDA8.83M
  • Revenue TTM70.04M
  • Revenue Per Share TTM1.16
  • Gross Profit TTM 40.66M
  • Diluted EPS TTM0.02

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 2.54M 0.94M 0.20M -1.60800M -0.35700M
Minority interest - - - 0.00000M 0.00200M
Net income 1.97M -0.07700M 0.23M -1.33800M -0.99600M
Selling general administrative 15.00M 14.48M 13.30M 12.72M 6.57M
Selling and marketing expenses 13.55M 12.28M 12.32M 11.86M 3.90M
Gross profit 40.66M 39.42M 36.56M 36.97M 37.34M
Reconciled depreciation 7.80M 8.40M 9.39M 9.49M 8.30M
Ebit 3.24M 1.99M 2.59M 2.20M -0.49400M
Ebitda 12.07M 10.19M 11.98M 11.69M 7.80M
Depreciation and amortization 8.84M 8.20M 9.39M 9.49M 8.30M
Non operating income net other - - - - -
Operating income 3.24M 1.99M 2.59M 2.20M 3.50M
Other operating expenses 67.22M 71.72M 67.83M 69.22M 68.97M
Interest expense 0.44M 0.45M 0.52M 0.62M 0.64M
Tax provision 0.58M 1.02M -0.03500M -0.27000M -0.13500M
Interest income 0.01M 0.00200M 0.01M 0.03M 0.07M
Net interest income -0.63200M -0.61400M -0.59400M -0.70600M -0.64700M
Extraordinary items - - - - -0.77600M
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.58M 1.02M -0.03500M -0.27000M -0.13500M
Total revenue 71.62M 74.02M 70.49M 71.12M 72.47M
Total operating expenses 36.26M 37.12M 33.90M 35.07M 33.84M
Cost of revenue 30.96M 34.61M 33.94M 34.15M 35.13M
Total other income expense net -0.69400M -1.04400M -2.39100M -3.81000M -3.85700M
Discontinued operations - - - - -0.77600M
Net income from continuing ops 1.97M -0.07700M 0.23M -1.33800M -0.22200M
Net income applicable to common shares 1.97M -0.07700M 0.23M -1.33800M -0.99600M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 118.24M 110.00M 124.44M 128.24M 143.55M
Intangible assets 25.28M 29.72M 37.81M 43.00M 51.33M
Earning assets - - - - -
Other current assets 0.71M 1.20M 1.59M 2.75M 15.82M
Total liab 39.26M 31.20M 42.84M 46.35M 56.95M
Total stockholder equity 78.99M 78.80M 81.59M 81.89M 86.59M
Deferred long term liab - - - - -
Other current liab 5.93M 2.16M 3.20M 2.80M 5.11M
Common stock 12.02M 12.02M 12.01M 12.01M 12.01M
Capital stock 12.02M 12.02M 12.01M 12.01M 12.01M
Retained earnings -11.97700M -11.67600M -9.44500M -8.64000M -4.73200M
Other liab 6.40M 6.51M 6.17M 5.89M 6.22M
Good will 50.85M 50.34M 50.99M 50.45M 50.94M
Other assets 3.64M 2.08M 2.27M 1.60M 1.99M
Cash 6.04M 5.63M 5.26M 6.17M 8.04M
Cash and equivalents - - - - -
Total current liabilities 22.27M 14.45M 19.38M 17.93M 19.76M
Current deferred revenue - 1.55M 3.24M 3.35M -
Net debt 5.40M 5.33M 13.62M 17.81M 23.59M
Short term debt 0.85M 0.72M 1.59M 1.44M 0.65M
Short long term debt - 0.00000M 0.64M 0.61M 0.65M
Short long term debt total 11.44M 10.96M 18.88M 23.98M 31.62M
Other stockholder equity 78.94M 78.46M 79.03M 78.52M 81.34M
Property plant equipment 3.37M 2.28M 2.06M 2.23M 0.48M
Total current assets 33.79M 24.30M 29.79M 30.90M 38.75M
Long term investments - - - - 0.06M
Net tangible assets 2.85M -1.25700M -7.20700M -11.56500M -15.67900M
Short term investments - - - - -
Net receivables 13.57M 7.13M 10.14M 10.89M 15.13M
Long term debt 8.43M 9.24M 16.43M 21.43M 30.98M
Inventory 13.47M 10.33M 12.80M 11.10M 14.89M
Accounts payable 15.50M 10.02M 11.35M 10.33M 11.91M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - -1.89300M -2.15300M -2.03200M
Additional paid in capital - - - - -
Common stock total equity - - 12.01M 12.01M 12.01M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 1.38M 0.02M 0.05M 0.07M 0.35M
Deferred long term asset charges - - - - -
Non current assets total 84.45M 85.71M 94.64M 97.34M 104.80M
Capital lease obligations 3.01M 1.72M 1.81M 1.94M -
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -3.11900M -0.28900M -0.59300M -0.59300M 0.46M
Change to liabilities 6.71M -2.69800M 0.88M -3.84200M 0.90M
Total cashflows from investing activities -3.11900M -2.96400M -2.90600M -2.39100M -1.91300M
Net borrowings -2.31600M -7.97600M -7.08800M -9.15300M -2.25700M
Total cash from financing activities -5.69600M -10.96300M -8.85800M -12.43900M -5.11400M
Change to operating activities - - - - -
Net income 2.54M 0.94M 0.20M -1.60800M -0.99600M
Change in cash 0.40M 0.37M -0.90000M -1.87000M 0.46M
Begin period cash flow 5.63M 5.26M 6.17M 8.04M 7.58M
End period cash flow 6.04M 5.63M 5.26M 6.17M 8.04M
Total cash from operating activities 9.43M 14.02M 11.12M 13.11M 7.43M
Issuance of capital stock 0.00000M 0.08M - 0.00000M 0.17M
Depreciation 7.80M 8.40M 9.39M 9.49M 8.30M
Other cashflows from investing activities - - -0.47100M - 2.87M
Dividends paid 2.64M 2.40M 1.20M 2.64M 2.40M
Change to inventory -2.73500M 1.36M -1.61500M 2.49M -1.20700M
Change to account receivables -5.87500M 3.54M 0.64M 3.10M -0.54000M
Sale purchase of stock - 0.05M - - 0.17M
Other cashflows from financing activities -1.73200M -0.21300M -1.65000M -1.69700M -0.62600M
Change to netincome 1.56M 3.50M 1.58M 3.20M 0.97M
Capital expenditures 2.95M 3.21M 2.44M 2.39M 4.78M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -1.90400M 2.20M -0.09200M 1.75M -0.84300M
Stock based compensation 0.54M 0.25M 0.16M 0.07M 0.01M
Other non cash items 0.45M 0.74M 0.59M 0.62M 0.96M
Free cash flow 6.48M 10.81M 8.68M 10.71M 2.65M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (GBP) Price (GBP) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ANCR
Animalcare Group Plc
-1.0 0.41% 240.00 85.00 - 1.50 1.29 1.55 11.21
HLN
Haleon PLC
-3.3 0.86% 380.60 24.73 16.86 2.63 1.81 3.17 16.57
HIK
Hikma Pharmaceuticals PLC
7.00 0.36% 1935.00 33.45 11.14 1.45 2.32 1.76 8.98
HCM
HUTCHMED China Ltd
2.00 0.85% 238.00 - - 3.22 3.97 2.39 -19.4252
INDV
Indivior PLC
-32.0 3.38% 913.50 - - 1.60 48.69 1.17 -4.7616

Reports Covered

Stock Research & News

Profile

Animalcare Group plc develops, sells, and distributes licensed veterinary pharmaceuticals and identification products, and services for companion and production animals, and equine veterinary markets. The company also offers microchipping and other associated services. It operates in Belgium, the Netherlands, the United Kingdom, Germany, Spain, Italy, Portugal, other European countries, Asia, the Middle East, Africa, and internationally. Animalcare Group plc is based in York, the United Kingdom.

Animalcare Group Plc

Moorside, York, United Kingdom, YO32 9LB

Key Executives

Name Title Year Born
Ms. Jennifer Ann Julia Winters B.Sc. CEO & Director 1960
Mr. Christopher James Brewster CFO, Company Sec. & Director 1977
Carla De Schepper Group HR Director NA
Mr. Jeroen Bastijns Head of Bus. Devel. NA
Mr. Emilio Gil Ventura Head of Strategy & Country Mang. of Spanish Bus. NA
Stephen Pearson Group Head of Supply Chain NA
Martin Gore Head of Commercial NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions